Inventor · disambiguated record
Michael Sworin
Also filed as: SWORIN MICHAEL
17 granted patents·8 pending applications·321 citations·filing 1994–2017
95Inventor score
Files withBRISTOL MYERS SQUIBB PHARMA CO6THRASOS INNOVATION INC4DU PONT MERCK PHARMA3MASSACHUSETTS INST TECHNOLOGY3CARLSON WILLIAM D1
Top patents by PatentIndex Score
25 records- 0191US9181301B2TDF-related compounds and analogs thereofTHRASOS INNOVATION INC·Filed 2014·Granted Nov 10, 2015·20 cites·10 claims
- 0291US6569402B1Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted May 27, 2003·24 cites·28 claims
- 0390US6022523ARadiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disordersDU PONT PHARM CO·Filed 1997·Granted Feb 8, 2000·46 cites·1 claims
- 0489US5750088AStable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticalsDU PONT MERCK PHARMA·Filed 1995·Granted May 12, 1998·49 cites·7 claims
- 0583US6818201B2Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 16, 2004·7 cites·55 claims
- 0681US6548663B1Benzodiazepine vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Apr 15, 2003·36 cites·4 claims
- 0780US6416733B1Radiopharmaceuticals for imaging infection and inflammationBRISTOL MYERS SQUIBB PHARMA CO·Filed 1997·Granted Jul 9, 2002·56 cites·11 claims
- 0878US8916686B2TDF-related compounds and analogs thereofTHRASOS INNOVATION INC·Filed 2013·Granted Dec 23, 2014·3 cites·10 claims
- 0977US8410246B2TDF-related compounds and analogs thereofCARLSON WILLIAM D·Filed 2005·Granted Apr 2, 2013·3 cites·10 claims
- 1076US9588095B2Reagents for oxidizer-based chemical detectionMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Mar 7, 2017·4 cites·20 claims
- 1164US5635477ACyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIADU PONT MERCK PHARMA·Filed 1995·Granted Jun 3, 1997·29 cites·22 claims
- 1262US11237143B2Reagents for oxidizer-based chemical detectionMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted Feb 1, 2022·0 cites·14 claims
- 1359US5879657ARadiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disordersDU PONT MERCK PHARMA·Filed 1994·Granted Mar 9, 1999·23 cites·70 claims
- 1457US6794109B2Low abosorbing resists for 157 nm lithographyMASSACHUSETTS INST TECHNOLOGY·Filed 2001·Granted Sep 21, 2004·4 cites·36 claims
- 1557US2003149262A1Benzodiazepine vitronectin receptor antagonist pharmaceuticalsFiled 2002·Application pending·0 cites
- 1657US2015126451A1Tdf-related compounds and analogs thereof, analogs and bioactive fragmentsTHRASOS INNOVATION INC·Filed 2014·Application pending·0 cites
- 1755US6558649B1Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted May 6, 2003·6 cites·9 claims
- 1854US2003007927A1Radiopharmaceuticals for imaging infection and inflammationFiled 2002·Application pending·0 cites
- 1951US7090828B2Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Aug 15, 2006·0 cites·14 claims
- 2050US2016152674A1Tdf-related compounds and analogs thereofTHRASOS INNOVATION INC·Filed 2015·Application pending·0 cites
- 2149US6015904AStable reagents for the preparation of radio pharmaceuticalsFiled 1997·Granted Jan 18, 2000·11 cites·11 claims
- 2249US2005221347A1Inhibitors of binding between proteins and macromolecular ligandsTHRASOS INC·Filed 2004·Application pending·0 cites
- 2340US2002182650A1Inhibitors of binding between proteins and macromolecular ligandsPOLARIS PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 2437US2003124053A1Radiopharmaceuticals for imaging infection and inflammationFiled 2002·Application pending·0 cites
- 2533US2004009424A1Protecting groups for lithographic resist compositionsMASS INST OF TECHNOLOGY MIT·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Sworin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →